Poseida Therapeutics, Inc.

Q2 2022 13F Holders

Symbol
PSTX
CUSIP
73730P108
Type
Equity
Class
COM
Num filings
57
Total reported value, excl. options
$58.1 M
Manager Report Date Value ($000) Shares Option Type